Captopril and L-arginine have a synergistic cardioprotective effect in ischemic-reperfusion injury in the isolated rat heart

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 5, Issue 4, 2000, Pages 281-290

  Greenberg, S ^a   Chernin, G ^a   Shapira, I ^a   George, J ^a   Wollman, Y ^a   Laniado, S ^a   Keren, G ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Captopril; Ischemia reperfusion; Isolated heart; L arginine

Indexed keywords

ARGININE; CAPTOPRIL; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG MIXTURE; DRUG POTENTIATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0033765408     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1054/JCPT.2000.18021     Document Type: Article

References (36)

1. Role of L-arginine in preventing myocardial and endothelial injury following ischemia/reperfusion in the rat isolated heart
2. Cardioprotection by ramiprilat in isolated rat hearts
3. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
4. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor
5. GISSI-3. Effects of Lisinopril and transdermal glyceryltrinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
6. Early prevention of left ventricular dysfunction with angiotensin-converting enzyme inhibition
7. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction
8. Effects of captopril on contractility after myocardial infarction: Experimental observations
9. Captopril in cardioplegia and reperfusion: Protective effects on the ischemic heart
10. Captopril, an ACE inhibitor, for optimizing reperfusion after myocardial infarction
11. Interaction of angiotensin converting enzyme inhibitors with the function of the sympathetic nervous
12. Effects of angiotensin-converting enzyme inhibition on circulating and local bradykinin levels
13. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: Effect of sulfydryl groups on endothelium derived relaxing factor
14. Effects of an angiotensin II antagonist on ischemic and non ischemic isolated rat hearts
15. Nitric oxide: Physiology, Pathophysiology and Pharmacology
16. Nitric oxide signaling in ischemic hearts
17. The protective effect of L-arginine on myocardial injury and endothelial function following ischemia and reperfusion in the pig
18. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischemic and reperfusion function of rat isolated heart
19. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure
20. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury
21. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischemiareperfusion injury
22. Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators
23. Nitric oxide in ischemic acute renal failure of Streptozotocin diabetic rats
24. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction a meta-analysis of randomized clinical trial
25. Intracardial generation of angiotensin and its physiologic role
26. Captopril-induced increase in coronary flow: An SH-dependent effect on arachidonic acid metabolism?
27. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat
28. Captopril and ramiprilat protect against free radical injury in dilated working rat hearts
29. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes
30. Antineutrophil and myocardial protecting actions of the novel nitric oxide donor after acute myocardial ischemia and reperfusion in the dogs
31. Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide
32. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation
33. Kinetic of superoxide dismutase and iron catalyzed nitration of phenolics by proxynitrite
34. Apparent hydroxyl radical production by peroxynitrite: Implication for endothelial injury from nitric oxide and superoxide
35. Improvement of ischemia-repeffusion induced myocardial dysfunction by modulating calcium overload using a novel specific calmodulin antagonist, CGS 9343B
36. Mechanisms of vascular smooth muscle relaxation by organic nitrate, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothinols as active intermediates